Taken together, our studies have demonstrated an increase in expression of PRLR receptors in breast cancer cells induced by endogenous PRL/PRLR action via STAT5 interaction with pERα and complex formation with Sp1/C/EBPβ at the PRLR promoter in the absence of estrogen (Figure 5). The gene discussed is STAT5B; the disease is breast cancer.